Clinical Trial Update: Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating dopaminergic enhancement of learning and memory in healthy adults and individuals with Alzheimer's disease or mild cogn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: University Hospital Muenster | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | Phase 4 | Status: UNKNOWN